LightNews LightNews
arnaudjannin.bsky.social
@arnaudjannin.bsky.social
15 followers 49 following 4 posts
Posts Replies Media Videos
Reposted
jedi-sfe.bsky.social
Retour sur le congrès #SFE2025 qui s'est tenu la semaine dernière à Lille : session des Essentiels, remise des bourses de congrès et de recherche à une centaine de lauréats, retour du tour de posters commentés animé par les JEDI, stand JEDI, soirée jeunes... revivez tous ces moments forts en image !
September 30, 2025 at 5:44 PM
Reposted
sfendocrino.bsky.social
📆WEBINAIRES SFE : Les RDV à ne pas manquer en octobre

10/10 : Post ECE et Actualités 2025
14/10 : Déficit en hormone de croissance (GH) chez l’adulte
21/10 : Acromégalie et IA

👉Inscriptions ici : www.sfendocrino.org/agenda/

#endocrinology #webinaireSFE #thyroïde #acromégalie #IA
Webinaire de la SFE sur le déficit en hormone de croissance Webinaire de la SFE Acromégalie et IA Webinaire de la SFE sur Post ECE et actualités 2025
October 6, 2025 at 11:36 AM
Reposted
jedi-sfe.bsky.social
🗳Une enquête de terrain importante menée par la Société Européenne d'Endocrinologie pour mieux comprendre l'état de l'Endocrinologie en Europe aujourd'hui et la façonner pour demain, à relayer sans modération vers vos équipes para-médicales 🙏👇

@jeromebertherat.bsky.social
@geraldraverot.bsky.social
sfendocrino.bsky.social Société Française d'Endocrinologie @sfendocrino.bsky.social · Oct 14
🚨 The State of Endocrinology Survey for Endocrine Nurses est ouvert !
L'ESE donne la parole aux infirmiers(ères). Le sondage est disponible en 9 langues et dure environ 20 minutes.

📅 Date limite 16/11
👉 Lien www.research.net/r/CBZ9J5Z?la...

A partager largement !

#endocrinology #nurse #survey
October 14, 2025 at 5:22 PM
Reposted
jeromebertherat.bsky.social
👏 👏 to the recipients of the research & travel grants of the French Endocrine Society , and 🙏 🙏to the @sfendocrino.bsky.social for supporting so many young endocrinologists ! 👇👇👇
September 25, 2025 at 3:53 PM
Reposted
sfendocrino.bsky.social
🔬 🔎 #SFE2025 - Retour sur la conférence grand public

Merci au Pr Francois Pattou pour sa présentation très claire hier soir sur "L'odyssée des îlots" durant laquelle la salle a pu comprendre l'importance du #pancréas, des îlots et les étapes et avancées sur la #greffe.

#endocrinologie #diabète
Salle remplie de personnes pour la conférence grand public du Pr François Pattou sur l'odyssée de la greffe des îlots Salle remplie de personnes pour la conférence grand public du Pr Pattou (CHU Lille) sur la greffe des îlots Conférence grand public du Pr Pattou sur la greffe des îlots, image du pancréas avec à l'intérieur les îlots Conférence grand public du Pr Pattou sur la greffe des îlots, image qui montre les centres en France qui pratiquent la greffe
September 25, 2025 at 12:26 PM
arnaudjannin.bsky.social
GTE symposium #SFE2025 @sfendocrino.bsky.social quelles thérapies dans les tumeurs endocrines ? Place aux associations !
September 25, 2025 at 9:21 AM
arnaudjannin.bsky.social
Excellente présentation de Christine Do Cao dans l'année en tumeur endocrine ! Le congrès de la SFE est lancé !
September 24, 2025 at 10:52 PM
Reposted
sfendocrino.bsky.social
💫 J.E.D.I : nouveau groupe SFE ! 🧑‍🔬👩‍🔬

4 lettres : 𝗝 (Jeunes) 𝗘 (Endocrinologues) 𝗗 (Dynamiques) 𝗜 (Innovants) qui ne vous feront plus penser aux guerriers de #StarWars mais à une nouvelle communauté, ambitieuse et amicale.
➡️@jedi-sfe.bsky.social
www.sfendocrino.org/groupe-jedi/
[email protected]
June 19, 2025 at 6:16 AM
Reposted
enets.org
Next week! Don’t miss our upcoming webinar exploring how tumour grade and differentiation impact treatment choices & patient outcomes in NETs and NECs.

When: 27 March, 18:00 - 19:10 CET
Where: Zoom
Register now: us06web.zoom.us/webinar/regi...
More on our website: www.enets.org/upcoming-web...
Welcome! You are invited to join a webinar: ENETS Webinar: Changes in grade & differentiation: what do we learn for patient management?. After registering, you will receive a confirmation email about ...
ENETS Webinar
us06web.zoom.us
March 18, 2025 at 1:52 PM
Reposted
halletjulie.bsky.social
Get to know the new CUTNETs group!

Clinical care, research & training to be combined to ⬆️ surgical care of NETs 🇨🇦🇮🇹🇺🇸🇲🇽🇬🇧🇳🇴🇸🇪🇦🇹🇩🇪🇳🇱

Stay tuned for our research agenda and first collaborative studies 🦓🤝

in @bjsurgery.bsky.social 🔗 tinyurl.com/5n6e8w84

#NETSky #SurgSky #OncSky @nanets.bsky.social
Care of neuroendocrine tumours: the Collaborative of sUrgical Teams for NeuroEndocrine Tumors (CUTNETs)
Neuroendocrine tumours (NETs) are a diverse group of malignancies with rising incidence and complex behaviours1,2. Although surgical management is a critic
tinyurl.com
February 6, 2025 at 3:04 PM
Reposted
halletjulie.bsky.social
🔥 from #ENETS25 - 🇨🇦 science on a big stage!💪🏻

@iacovosmichael.bsky.social using NETs organoids (my NET babies!) to test new Rx mechanisms
▪️apoptosis machinery active in G1/2 NETs
▪️BH3-mimetics + lutathera work in lab
👉🏻 New therapy to trial?

#NETsky #oncSky @nanets.bsky.social
March 6, 2025 at 2:28 PM
Reposted
enets.org
Congratulations to our founding member & former ENETS Chair, Philippe Ruszniewski, on receiving the ENETS Life Achievement Award 2025 from ENETS Chair Rocio Garcia-Carbonero. A well-deserved honour for his dedication and lifelong contributions to ENETS & NET science.
Thank you, Philippe!
#ENETS2025
March 6, 2025 at 3:33 PM
Reposted
sfendocrino.bsky.social
📅 Journées KLOTZ 12 et 13 Juin 2025 - Paris

Ne manquez pas les prochaines journées internationales d'endocrinologie clinique Henri-Pierre Klotz sur le thème "Hormones et Environnement".

📄 Programme : lnkd.in/dfVMf7WY
✍ Inscription en ligne sur le site de la SFE : lnkd.in/djKz_iK2
March 6, 2025 at 7:00 AM
Reposted
oncothor.bsky.social
PRRT + PARP inhibitors in advanced NETs? To date, no trials have convincingly shown that PRRT + drug X (whatever that may be) is better than PRRT alone. The addition of PARPi seems to add little early toxicity but larger trials needed to show efficacy.

jnm.snmjournals.org/content/earl...
177Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial
This phase I trial aimed to assess the feasibility and toxicity of combining the poly(adenosine diphosphate–ribose) polymerase inhibitor olaparib with 177Lu-DOTATATE in patients with somatostatin rece...
jnm.snmjournals.org
February 28, 2025 at 1:06 PM
Reposted
oncothor.bsky.social
Preparing for the ENETS annual conference next month. Here is a simplified vision of what might be the future in the world of radioligand therapy for NETs (RLT which I now prefer over PRRT as a term...).

Need better predictors of efficacy and tox

I have never been good at predicting...
February 23, 2025 at 6:06 PM
Reposted
geraldraverot.bsky.social
Et voilà SFE Xit…
connectez vous sans tarder au compte de la Société Française d’Endocrinologie
@sfendocrino.bsky.social

www.sfendocrino.org
#Endosky
@judithfavier.bsky.social @aldolabz.bsky.social @annebachelot.bsky.social
sfendocrino.bsky.social
sfendocrino.bsky.social
February 12, 2025 at 6:08 PM
Reposted
oncothor.bsky.social
New epidemiology data on gastroenteropancreatic
NETs (GEP-NETs) in the US. As I have said before and will continue saying, the incidence keeps rising (probably mostly from better diagnostic methods).

jamanetwork.com/journals/jam...
Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the US
This observational study reports on a comprehensive nationwide evaluation of rising gastroenteropancreatic neuroendocrine tumor incidence in the US from 2001 to 2020.
jamanetwork.com
January 24, 2025 at 2:02 PM
Reposted
inigolanda.bsky.social
[2/n]

First manuscript of these series is now out 🚨

Dutta & Knauf, from the @clevelandclinic.bsky.social, reviewed mouse models of aggressive #thyroidcancer, with a focus on novel approaches 🆕

Good stuff, read it here 👇

etj.bioscientifica.com/view/journal...
etj.bioscientifica.com
January 29, 2025 at 1:06 PM
Reposted
cronchi.bsky.social
📣January is #AdrenalCancerAwarenessMonth
Let’s talk about #AdrenoCorticalCarcinoma to fight it together! #ACC #AdrenalCancer #CureACC #EndoSky #MedSky @amenduk.bsky.social
January 25, 2025 at 8:30 AM
Reposted
joendocrinology.bsky.social
Read the latest article in Journal of Endocrinology's Exploring #Osteoporosis and #Sarcopenia Special Collection: 'The role of glucagon-like peptides in osteosarcopenia' by Enaya Tufail et al. 👉 doi.org/10.1530/JOE-24-0210 #GLP1
January 22, 2025 at 9:13 AM
Reposted
endocrineoncology.bsky.social
Po Hien Ear et al. highlight key insights from @socendocrinology.bsky.social's NET Models 2024. Experts discussed the current state of #neuroendocrine #tumor models, their limitations, and improvements for the future. Read it here 👉 https://doi.org/10.1530/EO-24-0055
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations By Po Hien Ear et al.
January 21, 2025 at 12:00 PM